Cutler Group LP Eiger Bio Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$4.99 - $8.96 $2,495 - $4,480	-500 Reduced 33.33%	1,000 $0
Q1 2022 Apr 14, 2022	BUY	$3.84 - $9.74 $5,760 - $14,610	1,500 New	1,500 $2,000
Q3 2021 Oct 26, 2021	SELL	$6.68 - $9.1 $13,360 - $18,200	-2,000 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$7.82 - $9.23 $24,242 - $28,613	-3,100 Reduced 60.78%	2,000 $0
Q1 2021 Apr 26, 2021	BUY	$8.44 - $12.66 $8,440 - $12,660	1,000 Added 24.39%	5,100 $1,000
Q4 2020 Jan 21, 2021	BUY	$7.98 - $12.29 $32,718 - $50,389	4,100 New	4,100 $7,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.